High-grade endometrial carcinomas - strategies for typing

Area of Science:

• Gynecologic Oncology
• Pathology
• Molecular Diagnostics

Background:

• Interobserver diagnostic agreement for high-grade endometrial carcinomas is low, potentially due to morphologically ambiguous cases.
• Microsatellite instability-high (MSI-H) is prevalent in ambiguous high-grade endometrial carcinomas.
• Prototypic high-grade endometrial carcinomas exhibit distinct genotypes and immunohistochemical profiles.

Purpose of the Study:

• To explore the link between morphological diagnoses, genetic signatures, and clinical outcomes in high-grade endometrial carcinomas.
• To investigate the utility of molecular assays in clarifying the origin and prognosis of morphologically ambiguous tumors.
• To address persistent challenges in tumor classification by evaluating evidence for refining diagnostic algorithms.

Main Methods:

• Analysis of genotypes and immunohistochemical profiles of high-grade endometrial carcinomas with prototypic morphology.
• Application of molecular assays to morphologically ambiguous endometrial carcinomas.
• Correlation of morphologically-based diagnoses with genetic signatures, expression profiles, and clinical outcomes.

Main Results:

• High-grade endometrial carcinomas with prototypic morphology possess characteristic genetic and immunohistochemical profiles.
• Molecular assays applied to ambiguous carcinomas may offer insights into tumor origin and clinical behavior.
• Demonstrating strong links between morphology, genetics, and clinical outcomes is crucial for diagnostic refinement.

Conclusions:

• Morphological ambiguity in high-grade endometrial carcinomas necessitates the integration of molecular data for accurate diagnosis and prognosis.
• Genotypic and immunohistochemical profiling can aid in classifying ambiguous tumors and predicting treatment response.
• Further critical evaluation of evidence is required to refine diagnostic algorithms for endometrial carcinomas.